OncoEthix's Series A - II Round

OncoEthix raised a round of funding on May 04, 2012.

OncoEthix is a Swiss-based privately held biotechnology Company that is developing a small portfolio of oncology drug candidates. The Company's lead product, OTX015, is an orally administered syntheti…

Articles about OncoEthix's Series A - II Round: